leisure time -WSS

leisure time

author：hotspot 2025-10-02 19:15:54 - browse：893

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Focused ultrasound for uterine fibroids: an uphill battle

WSS

New safety details link Apellis eye drug to rare cases of blindness

Dark money group runs ads on China biotech bill

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Physician groups backed by private equity giant lobby on mergers

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Childbirth

focus

leisure time

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Heart attack and stroke risk calculators need revising

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Prosthetic arm enables patients to feel the objects they grip

Activists slam private health insurers over coverage restrictions

Biohaven protein

Virginia high school admissions case could be legal follow

Health insurers say they are turning to AI to cut costs, improve care

Wikipedia

‘Oppenheimer’ and the risks of AI in health care

Mega Millions pot grows to $1.25 billion after no winner

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Startling documents reveal new facets of Sacklers' opioid empire

focus

hotspot

hotspot

entertainment